For example, we selected the low-density lipoprotein receptor (LDLR) promoter, where mutations have been shown to cause familial hypercholesterolemia (FH), a disorder that results in accelerated atherosclerosis and increased risk for coronary heart disease31–33. Here, LDLR is linked to familial hypercholesterolemia.